Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03957382 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Safety and Efficacy of the Accero® (Heal) Stent for Intracranial Aneurysm Treatment

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion date: Sep 1, 2026 to Mar 1, 2029
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Dec 31, 2026 to Mar 1, 2029
    • Site details revised at 4 of 4 sites
    v10
  2. Minor Eligibility criteria expanded, about 2 wordsv9
  3. Minor Study sites: 5 to 4
    • Interventions: Accero® Stent (Device) to Accero® (heal) Stent (Device)
    • Eligibility criteria expanded, about 1 word
    • Study title expanded, about 1 word
    v8
  4. Notable Primary completion date: Sep 1, 2024 to Sep 1, 2026
    • Study completion date: Dec 31, 2024 to Dec 31, 2026
    v7
  5. Minor Re-verified, no change to tracked fieldsv6
Show 4 earlier versionsHide 4 earlier versions
  1. Minor Study sites: 2 to 5v5
  2. Minor Re-verified, no change to tracked fieldsv4
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Enrollment target: 200 to 130
    • Study sites: 0 to 2
    • Start date changed from estimate of Jun 2019 to Jul 23, 2019
    v3
  4. Minor Secondary endpoints: details revised at 4 of 4 entriesv2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is intended to show that the application of the Accero® (heal) stent is safe within the given indication.
Trial Details
NCT Number NCT03957382
Lead Sponsor Acandis GmbH
Conditions
(from sponsor)
Intracranial Aneurysm
Related terms Intracranial Aneurysm
Enrollment 130 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov